Drug profile · INN
methimazole
METHIMAZOLE
methimazole (METHIMAZOLE) is a thyroid peroxidase inhibitor. Associated with Disc Medicine. Route of administration: oral. Current US regulatory status: approved.
Drug details — methimazole
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 2
- Data quality
- 0.89
Quick answer
methimazole (METHIMAZOLE) is a thyroid peroxidase inhibitor. Associated with Disc Medicine. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thyroid peroxidase inhibitor
Primary target: Thyroid peroxidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12396924
Adapter for use in a planetary mixer
granted -
US 12390497
Microbial strains for virus inhibition
granted -
US 12357702
Peptidic diagnostic compositions
granted -
US 12351590
Pyrrolopyrimidine compound and use thereof
granted -
US 12338218
Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate thereof, and preparation method thereof
granted -
US 12319684
Agonists of the apelin receptor and methods of use thereof
granted -
US 12312357
PRMT5 inhibiting compounds and uses thereof
granted -
US 12295909
Adapter for use in a planetary mixer
granted -
US 12290569
Methods and compositions using peptides and proteins with c-terminal elements
granted -
US 12285392
Method for modulating metabolism
granted -
US 12233145
Ultra-violet absorbing compounds
granted -
US 12223643
Machine-learning system for diagnosing disorders and diseases and determining drug responsiveness
granted -
US 12213941
Adapter for use in a planetary mixer
granted -
US 12215090
Agents and methods for treating dysproliferative diseases
granted -
US 12128014
Use of thiol compounds to treat neurological disease
granted -
US 12115198
Microbials for animals
granted -
US 12097264
Methods and compositions for theranostic nanoparticles
granted -
US 12071414
Apelin receptor agonists and methods of use thereof
granted
Frequently asked questions
What is methimazole?
methimazole (METHIMAZOLE) is a thyroid peroxidase inhibitor. Associated with Disc Medicine. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for methimazole?
METHIMAZOLE is a marketed brand name for methimazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methimazole?
methimazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.